Inside the heart of COVID-19.
作者信息
Adão Rui, Guzik Tomasz J
机构信息
Cardiovascular Research and Development Center, Faculty of Medicine of the University of Porto, Porto, Portugal.
Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
出版信息
Cardiovasc Res. 2020 May 1;116(6):e59-e61. doi: 10.1093/cvr/cvaa086.
Abstract
摘要
相似文献
1
Inside the heart of COVID-19.新冠疫情的核心
Cardiovasc Res. 2020 May 1;116(6):e59-e61. doi: 10.1093/cvr/cvaa086.
2
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.2019冠状病毒病（COVID-19）与心血管疾病：关于血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的发病和严重程度潜在影响的观点
J Am Heart Assoc. 2020 Apr 7;9(7):e016219. doi: 10.1161/JAHA.120.016219. Epub 2020 Apr 1.
3
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
4
[Hypertension, RAAS blockade and risk in COVID-19 patients].[高血压、肾素-血管紧张素-醛固酮系统阻断与新冠病毒感染患者的风险]
Lakartidningen. 2020 Jun 23;117:20102.
5
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).了解2019冠状病毒病（COVID-19）背景下的观察性治疗比较
JAMA Cardiol. 2020 Sep 1;5(9):988-990. doi: 10.1001/jamacardio.2020.1874.
6
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题？]
Lakartidningen. 2020 Apr 17;117:F3S3.
7
On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic.胸部X线摄影和CT在冠状病毒病（COVID-19）大流行中的作用
AJR Am J Roentgenol. 2020 Oct;215(4):W44. doi: 10.2214/AJR.20.23411. Epub 2020 Jun 15.
8
Coronavirus disease (COVID-19) pandemic.冠状病毒病（COVID-19）大流行。
Med J Malaysia. 2020 Mar;75(2):95-97.
9
How to deal and learn from the threat of COVID-19 in paediatric dentistry.如何应对和学习儿童牙科 COVID-19 威胁。
Eur J Paediatr Dent. 2020 Sep;21(3):173-175. doi: 10.23804/ejpd.2020.21.03.02.
10
Mental health during the coronavirus disease 2019 (Covid-19) pandemic: more is still to be done.2019冠状病毒病（Covid-19）大流行期间的心理健康：仍有更多工作要做。
Pan Afr Med J. 2020 Apr 16;35(Suppl 2):7. doi: 10.11604/pamj.2020.35.7.22605. eCollection 2020.
引用本文的文献
1
Risk factors for all-cause mortality during the COVID-19 pandemic compared with the pre-pandemic period in an adult population of Arkhangelsk, Russia.俄罗斯阿尔汉格尔斯克成年人群中，与疫情前时期相比，新冠疫情期间全因死亡率的风险因素。
Sci Rep. 2025 Jan 7;15(1):1050. doi: 10.1038/s41598-025-85360-0.
2
The home-based breathing and chest mobility exercise improves cardiorespiratory functional capacity in long COVID with cardiovascular comorbidities: a randomized study.家庭呼吸和胸廓运动锻炼改善长新冠合并心血管共病患者的心肺功能：一项随机研究。
BMC Cardiovasc Disord. 2024 Oct 18;24(1):574. doi: 10.1186/s12872-024-04196-0.
3
RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity.针对 COVID-19 疫苗的 RNA 编辑：揭示宿主免疫的动态表观遗传调控。
Front Immunol. 2024 Sep 6;15:1413704. doi: 10.3389/fimmu.2024.1413704. eCollection 2024.
4
Cardiovascular Diseases Increased among the Rural and Urban Population of the Northern Regions of the Republic of Kazakhstan during COVID-19: A Descriptive Study with Forecasting.哈萨克斯坦共和国北部地区城乡人口在新冠疫情期间心血管疾病增加：一项带预测的描述性研究
Rev Cardiovasc Med. 2024 Mar 8;25(3):100. doi: 10.31083/j.rcm2503100. eCollection 2024 Mar.
5
Ocular A-to-I RNA editing signatures associated with SARS-CoV-2 infection.与 SARS-CoV-2 感染相关的眼部 A-to-I RNA 编辑特征。
BMC Genomics. 2024 May 1;25(1):431. doi: 10.1186/s12864-024-10324-z.
6
Subclinical Left Ventricular Systolic Dysfunction in Hospitalized Patients with COVID-19 by Strain: A 30-Day Echocardiographic Follow-Up.住院 COVID-19 患者的应变亚临床左心室收缩功能障碍：30 天超声心动图随访。
Medicina (Kaunas). 2023 Nov 23;59(12):2065. doi: 10.3390/medicina59122065.
7
(L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.(L.) Dunal（冬氨酸）在 SARS-CoV-2 感染的可能治疗和临床管理中的应用：基于植物的药物发现和靶向治疗。
Front Cell Infect Microbiol. 2022 Aug 15;12:933824. doi: 10.3389/fcimb.2022.933824. eCollection 2022.
8
I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections.我现在从正反两方面看待肠道：胃肠道在 SARS-CoV-2 和 HIV/SIV 感染发病机制中的作用。
Front Immunol. 2022 Aug 12;13:899559. doi: 10.3389/fimmu.2022.899559. eCollection 2022.
9
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染相关血栓形成风险的病理生理机制、诊断及治疗综述
Int J Cardiol Heart Vasc. 2022 Aug;41:101068. doi: 10.1016/j.ijcha.2022.101068. Epub 2022 Jun 3.
10
Potential adverse effects of coronavirus disease 2019 on the cardiovascular system.2019冠状病毒病对心血管系统的潜在不良影响。
Cardiol Plus. 2021 Jan 1;6(1):30-40. doi: 10.4103/2470-7511.312592. Epub 2021 Mar 30.
本文引用的文献
1
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
2
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.血管紧张素转换酶2（ACE2）作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的受体：分子机制与潜在治疗靶点
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
5
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
6
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
7
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
The enigma of anti-inflammatory therapy for the management of heart failure.用于心力衰竭治疗的抗炎疗法之谜。
Cardiovasc Res. 2020 Jan 1;116(1):6-8. doi: 10.1093/cvr/cvz270.
Zotero 插件